|4Oct 5, 6:35 PM ET

Jafri Hasan 4

4 · Aridis Pharmaceuticals, Inc. · Filed Oct 5, 2021

Insider Transaction Report

Form 4
Period: 2021-10-04
Jafri Hasan
Chief Medical Officer
Transactions
  • Award

    Stock Options

    2021-10-04+30,000120,000 total
    Exercise: $3.60Exp: 2031-10-04Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The stock options vest in equal installments over 48 months, beginning on October 4, 2021.

Documents

1 file
  • 4
    tm2129291-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT